47
Participants
Start Date
October 31, 2010
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
ampicillin sodium/sulbactam sodium
ampicillin sodium/sulbactam sodium is administered 12g/day (3 g four times a day) intravenously for 3 to 14 days
Tosei General Hospital, Seto-shi
Fukuoka Sanno Hospital, Fukuoka
National Hospital Organization Kokura Medical Center, Kitakyushu
University of Occupational and Environmental Health, Kitakyushu
Nagata Hospital, Yanagawa
National Hospital Organization Asahikawa Medical Center, Asahikawa
National Hokkaido Medical Center, Sapporo
National Hospital Organization Himeji Medical Center, Himejishi
KKR Takamatsu Hospital, Takamatsu
Nippon Koukan Hospital, Kawasaki
Kanagawa Cardiovascular and Respiratory Center, Yokohama
National Hospital Organization Kochi National Hospital, Kochi
National Hospital Organization Kumamoto Saishyunsou Hospital, Koushi-shi
Saiseikai Kumamoto Hospital, Kumamoto
Saka General Hospital/Respiratory, Shiogama
National Hospital Organization Matsumoto Medical Center Chushin Matsumoto Hospital, Matsumoto
Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Isahaya
Nagasaki University School of Medicine, Nagasaki
National Hospital Organization Minami-Okayama Medical Center, Tsukubo-gun
National Hospital Organization Ureshino Medical Center, Ureshino-shi
Sekishinkai Sayama Hospital, Sayama
National Hospital Organization Tenryu National Hospital, Hamamatsu
Lead Sponsor
Pfizer
INDUSTRY